Star Imaging and Path Lab Limited IPO launch date is set for August 8, 2025, and will close on August 12, 2025. Through this IPO, Star Imaging and Path Lab Limited aims to raise ₹69.47 crores from the public. They are issuing 39.20 lakh new shares to raise ₹55.66 crores. An additional 9.72 lakh shares are being sold by existing shareholders, amounting to ₹13.80 crores.
Star Imaging and Path Lab IPO shares are priced between ₹135 and ₹142 per share.
The minimum application size for HNIs is 3 lots, amounting to ₹4,26,000. Investors can expect the allotment of IPO for Star Imaging to be finalized on Wednesday, August 13, 2025.
Star Imaging and Path Lab Limited IPO is tentatively scheduled to list on the BSE SME platform on Monday, August 18, 2025.
Check the steps to apply for Star Imaging and Path Lab Limited IPO!
STAR IMAGING AND PATH LAB SME IPO Details
| Detail | Information |
| IPO Opening Date | August 8, 2025 |
| IPO Closing Date | August 12, 2025 |
| Tentative IPO Listing Date | August 18, 2025 |
| Face Value | ₹10 per share |
| Price Range | ₹135 to ₹142 per share |
| Lot Size | 2000 shares |
| Total Issue Size | 48,92,000 shares (₹69.47 Cr.) |
| Reserved For Market Maker | 4,80,000 shares (₹6.82 Cr.) |
| Net Offered to Public | 44,12,000 shares (₹62.65 Cr.) |
| Fresh Issue (Ex-Market Maker) | 4327200 Shares (₹97.36 Cr.) 39.20 lakh shares (₹55.66 Cr.) |
| IPO Segment | Book Building Issue |
| Listing At | NSE SME |
Star Imaging and Path Lab Limited | Company Overview
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company offering a broad spectrum of diagnostic services.
Star Imaging and Path Lab Limited has over three decades of expertise in the healthcare domain, and its unique selling proposition includes its ability to cater to all three segments of the healthcare value chain:
- Panels
- Referrals and
- Preventive care
The diagnostic brand is located in Delhi, NCR.
The key focus of the brand is to employ world class innovation to provide precise and most recent investigations of the diagnostics world.
They provide services in medical-related tests.
Apply for the Star Imaging and Path Lab IPO using a free Demat Account today!
Star Imaging and Path Lab IPO | Key Details
- Star Imaging and Path Lab IPO Opening Date: August 8, 2025,
- Star Imaging IPO Closing Date: August 12, 2025.
- Star Imaging IPO Allotment Date: August 13, 2025
- Star Imaging IPO Price Band: ₹135 to ₹142 per share
- Star Imaging and Path Lab IPO Lot Size: 2000 shares
- Refunds Initiated: August 14, 2025
- Shares Credited to Demat: August 14, 2025
- Star Imaging and Path Lab Listing Date: August 18, 2025
Star Imaging and Path Lab Limited: Financial Overview
Star Imaging & Path Lab Ltd.’s earnings grew by 5% and profit after tax (PAT) shot up by 28% during FY25.
Here is a snapshot of the financials-
| Financial Information | 31-Mar-25 | 31-Mar-24 | Change | Change (%) |
| Assets | 98.16 | 81.64 | 16.52 | 20.24 |
| Revenue | 83.79 | 79.97 | 3.82 | 4.78 |
| Profit After Tax | 15.96 | 12.45 | 3.51 | 28.19 |
| EBITDA | 28.60 | 22.34 | 6.26 | 28.02 |
| Net Worth | 47.15 | 31.35 | 15.80 | 50.40 |
| Reserves & Surplus | 33.65 | 29.85 | 3.80 | 12.73 |
| Total Borrowing | 32.73 | 30.64 | 2.09 | 6.83 |
Amounts in ₹ Crore
Star Imaging and Path Lab Limited IPO | FAQs
Star Imaging and Path Lab Limited is committed to delivering a comprehensive array of diagnostic services across a wide spectrum of healthcare solutions.
The tentative IPO listing date of Star Imaging and Path Lab Limited IPO has been planned for Monday, 18 August 2025.
The bidding date for the Star Imaging and Path Lab is August 8, 2025, and it will continue until August 12, 2025.
The minimum IPO lot size for Star Imaging and Path Lab is 2000 shares.
The IPO allotment is expected to be finalised on Wednesday, August 13, 2025.
Star Imaging and Path Lab Limited IPO face value is set at ₹10 per share.
You can check the IPO allotment status for Star Imaging IPO via the official registrar’s website, Kfin Technologies Limited.
______________________________________________________________________________________
Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing.